NIIMBL Annual Report 2019-20

Biopharmaceutical, COVID-19

We are pleased to share NIIMBL’s 2019-2020 Annual Report covering the period from March 2019 through February 2020. It celebrates their collective accomplishments, which reflect the commitment and engagement of diverse individuals and organizations across the biopharmaceutical manufacturing ecosystem.

As they share and reflect on NIIMBL’s many accomplishments over the last year, the world is experiencing the global crisis brought about by the rise and spread of COVID-19. Their community is responding through an unprecedented effort to accelerate the development and commercialization of medical countermeasures and vaccines, and many of their stakeholders are tirelessly working and collaborating to develop and bring these products to market as fast as possible.

NIIMBL Annual Report 2019 - 2020

Beyond these important efforts, there are critical talent development initiatives underway in response to the economic downturn. Moreover, they know individuals from their community are employing their technical expertise in new and creative ways to prevent, prepare for, and respond to pandemic related efforts.

In the face of such challenges, diversity of perspectives, of expertise, and of experiences strengthens our ability to create and develop innovative solutions to today’s problems and to prepare for tomorrow’s needs.

Over the past year, they have made significant strides towards realizing this vision, and they look forward to accelerating our progress in the coming year. 

NIIMBL Annual Report 2019 - 2020